Cambridge Healthtech Institute’s Third Annual

Digital Innovation in Clinical Trials

Digital Biomarkers and Real-World Evidence Enabling Patient-Centric Clinical Development

June 2-4, 2020


Digital medicine tools are promising to revolutionize clinical trials by introducing new digital biomarkers and endpoints, enabling real-world data generation, and facilitating patient centricity. CHI’s Third Annual Digital Innovation in Clinical Trials will bring together clinical trial experts to discuss strategies to integrate sensors, wearables, mHealth and mobile devices for digital measurements, continuous patient monitoring, real-world evidence, patient engagement, and ultimately the impact on drug development at big pharma.

Preliminary Agenda

Tuesday, June 2

PLENARY SESSION: DIGITAL TRANSFORMATION IN HEALTHCARE

Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions

Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health

Driving Digital Transformation Success

Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center

Talk Title to be Announced

Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare

Delivering Digital Health in a Consumer Health World

Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens

The Future of Health Has Arrived: The Rise of Smart Health Communities

Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

DIGITAL TECHNOLOGY-ENABLED CLINICAL TRIALS

Clinical Trials in the Digital Age: Moving from Site-Centric to Patient-Centric Clinical Trials

Lisa Shipley, Vice President, Global Digital Analytics and Technologies, Merck Research Laboratories

Operationalizing Digital Wearable Devices in Large Clinical Trials – Lessons Learned and Still Learning

Carrie Northcott, PhD, Director, Early Clinical Development, Digital Medicine, Pfizer

Enhancing Clinical Understanding Through Sensor-Based Data Generation

Lauren Bataille, MS, Director, Digital Strategy Lead, Novartis

Regulatory Considerations During Mobile Medical App Development for Commercial and Clinical Trial Use

Michael J. Benecky, PhD, Senior Director, Global Regulatory Affairs, Precision and Digital Medicine, GlaxoSmithKline

 

PLENARY SESSION: BRIDGING SILOS: AN INTEGRATED APPROACH TO DIGITAL HEALTH

Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital

Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity


 

Wednesday, June 3

PLENARY Session: Digital Health Innovation

PANEL DISCUSSION: Investing in Digital Health Innovation

Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists:
David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

Delivering Global Comprehensive Virtual Care at Scale

Lewis Levy, MD, FACP, CMO, Teladoc

 

Additional Company Presentations to be Announced

DIGITAL BIOMARKERS

Naturalistic Measurement with Digital Technology and the Convergence of Clinical Trials and the Real World

Daniel R. Karlin, MD, MA, CEO, HealthMode

Picking the Right Device for Your Digital Biomarker

Joseph Kim, MBA, Senior Advisor, Digital Health, Eli Lilly

Faster, Smaller, Better: Choose Three! Quantitative Tools That are Powering Digital Measures in Development

Peter Bergethon, MD, FAAN, FANA, Vice President and Head, Digital and Quantitative Medicine, Biogen, Inc.

PANEL DISCUSSION: Digital Biomarkers

Moderator: Daniel R. Karlin, MD, MA, CEO, HealthMode

 

Thursday, June 4

SENSORS, WEARABLES, AND IoT IN DIGITAL HEALTH

The ‘Tyranny of Distance’ to Cancer Patient Outcomes: Implementation Strategies of Remote Monitoring to Broaden the Umbrella of Cancer Care

Christopher M. Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

How is Wearables-Driven Digital Health Shaping Non-Critical Care?

Ravi Kuppuraj, PhD, CEO, Digital Innovator, Connected Sensing – General Care Solutions, Philips

Clinical Wearables as a Source for Real World Evidence

Carlos Agell, Program Manager, Connected Health Solutions, imec

PLENARY SESSION: EVIDENCE-Based DIGITAL MEDICINE

Talk Title to be Announced

Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

PANEL DISCUSSION: Real World Impact of Digital Medicine

Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai




For more details on the conference, please contact:
Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute
Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Jon Stroup

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5483
Email: jstroup@healthtech.com

 

Companies L-Z

Joseph Vacca, M.S.

Director, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5431
Email: jvacca@healthtech.com